General Resources
These resources relate to the issues that MeTA is concerned with, both internally and externally produced. Clicking on one of the links may take you away from the MeTA website, to the source of that information.
Multi-stakeholder process resource portal – Wageningen University
This portal has theoretical foundations, methods, tools, facilitation tips, examples and literature to help facilitate participatory learning processes with various stakeholders.
Drug giant GlaxoSmithKline pledges cheap medicine for world's poor
The world's second biggest pharmaceutical company is to radically shift its attitude to providing cheap drugs to millions of people in the developing world.
Measuring medicine prices, availability, affordability and price components 2ND EDITION
The second edition of the manual for the Health Action International/World Health Organization pricing survey tool.
Corruption in the Health Sector (updated 2008)
This U4 Issue presents some essential resources for anyone promoting anti-corruption in the health sector, or wanting to learn about the challenges of corruption in the sector.
Medicine Pricing Matters Issue 4
This issue includes interesting articles on pricing policy reforms in China and the establishment of retail outlets in India that sell only unbranded generics.
Untangling the Web of Antiretroviral Price Reductions
The 11th edition of this report shows the evolution of ARV prices and highlights the continuing gaps in treatments needed for patients in developing countries. Also available in Spanish, French and Portuguese.
Poverty, not pharmaceutical patents, is the leading factor to a lack of access to essential medicines in developing countries.
A study from the Royal Institute of International affairs suggests that rather than patents limiting access to essential medicines in developing countries, it is poverty.
High inefficiency cited in distribution of medicine
A report of the MeTA Ghana launch from the Ghana News Agency
Promoting Transparency and Accountability in the Procurement and Distribution of Medicines
What is already known about demand for medicines and what further research is needed?